State-of-the art facility to develop and manufacture

High potent cytotoxic drugs

New unit for High potent APIs and intermediates (HPAPI), fully integrated on PROCOS site with dedicated facilities from R&D to cGMP production:

  • R&D laboratory for process and analytical development
  • Quality Control laboratory for analytical and GMP release testing
  • 2 Operation Units for HPAPI small scale manufacturing: up to 5 Kg batch
  • 17 isolators
  • High confined area
  • Dedicated warehouse and waste treatments
  • High containment: down to 30 ng/m3.

Logo AIFA   Just authorized